253 related articles for article (PubMed ID: 17327260)
1. Diagnosis of lung cancer by the analysis of exhaled breath with a colorimetric sensor array.
Mazzone PJ; Hammel J; Dweik R; Na J; Czich C; Laskowski D; Mekhail T
Thorax; 2007 Jul; 62(7):565-8. PubMed ID: 17327260
[TBL] [Abstract][Full Text] [Related]
2. An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD.
Dragonieri S; Annema JT; Schot R; van der Schee MP; Spanevello A; Carratú P; Resta O; Rabe KF; Sterk PJ
Lung Cancer; 2009 May; 64(2):166-70. PubMed ID: 18834643
[TBL] [Abstract][Full Text] [Related]
3. Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study.
Westhoff M; Litterst P; Freitag L; Urfer W; Bader S; Baumbach JI
Thorax; 2009 Sep; 64(9):744-8. PubMed ID: 19158121
[TBL] [Abstract][Full Text] [Related]
4. Progress in the development of volatile exhaled breath signatures of lung cancer.
Mazzone PJ; Wang XF; Lim S; Jett J; Choi H; Zhang Q; Beukemann M; Seeley M; Martino R; Rhodes P
Ann Am Thorac Soc; 2015 May; 12(5):752-7. PubMed ID: 25965541
[TBL] [Abstract][Full Text] [Related]
5. A study of the volatile organic compounds exhaled by lung cancer cells in vitro for breath diagnosis.
Chen X; Xu F; Wang Y; Pan Y; Lu D; Wang P; Ying K; Chen E; Zhang W
Cancer; 2007 Aug; 110(4):835-44. PubMed ID: 17599760
[TBL] [Abstract][Full Text] [Related]
6. Exhaled breath analysis with a colorimetric sensor array for the identification and characterization of lung cancer.
Mazzone PJ; Wang XF; Xu Y; Mekhail T; Beukemann MC; Na J; Kemling JW; Suslick KS; Sasidhar M
J Thorac Oncol; 2012 Jan; 7(1):137-42. PubMed ID: 22071780
[TBL] [Abstract][Full Text] [Related]
7. Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study.
Poli D; Carbognani P; Corradi M; Goldoni M; Acampa O; Balbi B; Bianchi L; Rusca M; Mutti A
Respir Res; 2005 Jul; 6(1):71. PubMed ID: 16018807
[TBL] [Abstract][Full Text] [Related]
8. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
[TBL] [Abstract][Full Text] [Related]
9. Quantitative breath analysis of volatile organic compounds of lung cancer patients.
Song G; Qin T; Liu H; Xu GB; Pan YY; Xiong FX; Gu KS; Sun GP; Chen ZD
Lung Cancer; 2010 Feb; 67(2):227-31. PubMed ID: 19409642
[TBL] [Abstract][Full Text] [Related]
10. Volatile signature for the early diagnosis of lung cancer.
Gasparri R; Santonico M; Valentini C; Sedda G; Borri A; Petrella F; Maisonneuve P; Pennazza G; D'Amico A; Di Natale C; Paolesse R; Spaggiari L
J Breath Res; 2016 Feb; 10(1):016007. PubMed ID: 26857451
[TBL] [Abstract][Full Text] [Related]
11. Rapid recognition of volatile organic compounds with colorimetric sensor arrays for lung cancer screening.
Zhong X; Li D; Du W; Yan M; Wang Y; Huo D; Hou C
Anal Bioanal Chem; 2018 Jun; 410(16):3671-3681. PubMed ID: 29654337
[TBL] [Abstract][Full Text] [Related]
12. Analysis of volatile organic compounds in the exhaled breath for the diagnosis of lung cancer.
Mazzone PJ
J Thorac Oncol; 2008 Jul; 3(7):774-80. PubMed ID: 18594325
[TBL] [Abstract][Full Text] [Related]
13. Exhaled biomarkers in lung cancer.
Horváth I; Lázár Z; Gyulai N; Kollai M; Losonczy G
Eur Respir J; 2009 Jul; 34(1):261-75. PubMed ID: 19567608
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of canine scent detection in early- and late-stage lung and breast cancers.
McCulloch M; Jezierski T; Broffman M; Hubbard A; Turner K; Janecki T
Integr Cancer Ther; 2006 Mar; 5(1):30-9. PubMed ID: 16484712
[TBL] [Abstract][Full Text] [Related]
15. Breath analysis in non small cell lung cancer patients after surgical tumour resection.
Poli D; Goldoni M; Caglieri A; Ceresa G; Acampa O; Carbognani P; Rusca M; Corradi M
Acta Biomed; 2008; 79 Suppl 1():64-72. PubMed ID: 18924311
[TBL] [Abstract][Full Text] [Related]
16. Angiogenic markers in breath condensate identify non-small cell lung cancer.
Gessner C; Rechner B; Hammerschmidt S; Kuhn H; Hoheisel G; Sack U; Ruschpler P; Wirtz H
Lung Cancer; 2010 May; 68(2):177-84. PubMed ID: 19647334
[TBL] [Abstract][Full Text] [Related]
17. Sex and Smoking Status Effects on the Early Detection of Early Lung Cancer in High-Risk Smokers Using an Electronic Nose.
McWilliams A; Beigi P; Srinidhi A; Lam S; MacAulay CE
IEEE Trans Biomed Eng; 2015 Aug; 62(8):2044-54. PubMed ID: 25775482
[TBL] [Abstract][Full Text] [Related]
18. Non-invasive phenotyping using exhaled volatile organic compounds in asthma.
Ibrahim B; Basanta M; Cadden P; Singh D; Douce D; Woodcock A; Fowler SJ
Thorax; 2011 Sep; 66(9):804-9. PubMed ID: 21749985
[TBL] [Abstract][Full Text] [Related]
19. A profile of volatile organic compounds in breath discriminates COPD patients from controls.
Van Berkel JJ; Dallinga JW; Möller GM; Godschalk RW; Moonen EJ; Wouters EF; Van Schooten FJ
Respir Med; 2010 Apr; 104(4):557-63. PubMed ID: 19906520
[TBL] [Abstract][Full Text] [Related]
20. 3p microsatellite signature in exhaled breath condensate and tumor tissue of patients with lung cancer.
Carpagnano GE; Foschino-Barbaro MP; Spanevello A; Resta O; Carpagnano F; Mulé G; Pinto R; Tommasi S; Paradiso A
Am J Respir Crit Care Med; 2008 Feb; 177(3):337-41. PubMed ID: 17962633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
